| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to use of 2-(R-thio)-10-[3-(4-R-piperazin-1-yl)propyl]-10H-phenothiazine according to general formula I for treating a β-amyloidopathy or α-synucle- opathy followed by a cerebral protein deposit and reduced activity of cerebral ABCC1-transporter, including Alzheimer's dementia, Parkinson's disease or Lewy body dementia. According to general formula I R- Methyl group, R- Ethyl group, R- Hydrogen and R- Hydrogen.EFFECT: treatment of β-amyloidopathy or α-synucleopathy.3 cl, 12 dwg |
